1. Clinical update on alefacept: consideration for use in patients with psoriasis;Gade;J. Manag. Care Pharm.,2004
2. Chronic plaque psoriasis;Luba;Am. Fam. Physician,2006
3. National Psoriasis Foundation 2012 Statistics http://www.psoriasis.org/learn_statistics
4. Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor;Bassel-Duby;J. Biol. Chem.,1992
5. The pathogenesis of psoriasis: immunological facts and speculations;Bos;Immunol. Today,1999